InvestorsHub Logo
Followers 46
Posts 4621
Boards Moderated 0
Alias Born 11/19/2006

Re: $ubmachine post# 62

Thursday, 04/13/2023 6:26:05 AM

Thursday, April 13, 2023 6:26:05 AM

Post# of 76
ACIU clinical stage programs
ACI-7104 and ACI-12589
Their ACI-7104 and ACI-12589 is on alpha-synuclein for Parkinsons desease

Novel targets programs:
Anti-a-syn antibody and Morphomer® a-syn aggregation inhibitor on alpha-synuclein for Parkinsons desease
$$$
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ACIU News